Description
A potent inhibitor of phosphatidic acid formation (IC50 = 0.6 µM) through cytokine-activated LPAAT; suppresses the production of IFN-γ, inhibits IL-12-mediated STAT-4 activation, and enhances glucose-stimulated β-cell insulin secretion; reduces the onset of diabetes in a non-obese diabetic mouse model